TotalMarketCap

Eledon Pharmaceuticals

ELDNNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$199.902 M

$2.46 -8.89%

Close of 6 Nov 2026

As of 6 Nov 2026, Eledon Pharmaceuticals (ELDN) has a market capitalization of $199.9M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

-$45.6M

Loss-making

Shares outstanding

81,261,152

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #246Cartesian TherapeuticsRNAC$205.2M
  2. #247Bright Minds BiosciencesDRUG$201.3M
  3. #248Eledon PharmaceuticalsELDN$199.9M
  4. #249InflaRxIFRX$198.9M
  5. #250Pyxis OncologyPYXS$193.1M

What if Eledon Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$347,483.06

Per share 141,253× higher

Bitcoin $1.53T

$18,801.70

Per share 7,643× higher

Apple $5.02T

$61,724.24

Per share 25,091× higher

Or at a round number

$500.0M$1.00B$2.00B$5.00B

Where these numbers come from

Share counts and financials for Eledon Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.